Multi-susceptibility genes associated with the risk of the development stages of esophageal squamous cell cancer in Feicheng County

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Li, Qing D ^a   Li, Hao ^a   Wang, Mei S ^b   Diao, Tao Y ^c   Zhou, Zhi Y ^b   Fang, Qiang X ^d   Yang, Fang Y ^e   Li, Qing H ^c  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d Shandong University ^*  (China)

^e Department of Epidemiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CYTOCHROME P450 2E1; CYTOSINE; GUANINE; MYELOPEROXIDASE; THYMINE; ALDEHYDE DEHYDROGENASE; ALDH2 PROTEIN, HUMAN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ALDH2 GENE; ARTICLE; BASAL CELL HYPERPLASIA; C326G GENE; C677T GENE; CARCINOGENESIS; CHINA; CONTROLLED STUDY; CYP2E1 GENE; DEVELOPMENTAL STAGE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGEAL SQUAMOUS CELL DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS DISEASE; FEMALE; G1259C GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HOGG1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MPO G463A GENE; SQUAMOUS EPITHELIUM; TUMOR GENE; CASE CONTROL STUDY; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ALDEHYDE DEHYDROGENASE; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 79958281909     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-74     Document Type: Article

References (37)

1. Wang LD, Zhou Q, Yang CS. Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area. J Cell Biochem Suppls 1997, 28/29:159-165.
2. Shimizu M, Ban S, Odze RD. Squamous Dysplasia and Other Precursor Lesions Related to Esophageal Squamous Cell Carcinoma. Gastroenterol Clin N Am 2007, 36:797-811.
3. Kuwano H, Watanabe M, Sadanaga N, Ikebe M, Mori M, Sugimachi K. Squamous epithelial dysplasia associated with squamous cell carcinoma of the esophagus. Cancer Lett 1993, 72:141-147. 10.1016/0304-3835(93)90120-X, 8402583.
4. Schlemper RJ, Dawsey SM, Itabashi M, Iwashita A, Kato Y, Koike M, Lewin KJ, Riddell RH, Shimoda T, Sipponen P, Stolte M, Watanabe H. Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer 2000, 88:996-1006. 10.1002/(SICI)1097-0142(20000301)88:5<996::AID-CNCR8>3.0.CO;2-Q, 10699887.
5. Rubio CA, Liu FS, Zhao HZ. Histological classification of intraepithelial neoplasias and microinvasive squamous carcinoma of the esophagus. Am J Surg Pathol 1989, 13:685-690. 10.1097/00000478-198908000-00007, 2751041.
6. Qiu SL, Yang GR. Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer 1988, 62:551-557. 10.1002/1097-0142(19880801)62:3<551::AID-CNCR2820620319>3.0.CO;2-Y, 3390795.
7. Wang LD, Yang HH, Fan ZM, Lü XD, Wang JK, Liu XL, Sun Z, Jiang YN, He X, Zhou Q. Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China. Cancer Detect Prev 2005, 29:317-322. 10.1016/j.cdp.2005.06.004, 16118042.
8. Dawsey SM, Lewin KJ, Wang GQ, Liu FS, Nieberg RK, Yu Y, Li JY, Blot WJ, Li B, Taylor PR. Squamouse esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 1994, 74:1686-1692. 10.1002/1097-0142(19940915)74:6<1686::AID-CNCR2820740608>3.0.CO;2-V, 8082069.
9. Wang GQ. Clinical preventive strategies to decrease incidence and death rates of esophageal cancer in high-risk areas. Zhonghua Zhongliu Zazhi 1999, 21:223.
10. Wang LD, Zhou Q, Feng CW, Liu B, Qi YJ, Zhang YR. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Gan to Kagaku Ryoho 2002, 29(Suppl 1):159-172.
11. Yang GR, Oiu SL. Endoscopie surveys in high-risk populations for esophageal cancer in China with special reference to precursors of esophageal cancer. Endoscopy 1987, 19:91-95. 10.1055/s-2007-1018250, 3608927.
12. Yang CX, Matsuo K, Ito H, Hirose K, Wakai K, Saito T, Shinoda M, Hatooka S, Mizutani K, Tajima K. Esophageal cancer risk by ALDH2 and ADH2 polymorphisms and alcohol consumption: exploration of gene-environment and gene-gene interactions. Asian Pac J Cancer Prev 2005, 6:56-62.
13. Nishimura FT, Kimura Y, Abe S, Fukunaga T, Saijoh K. Effect of -361 ALDH2*1/ALDH2*2 polymorphism of aldehyde dehydrogenase-2 gene on alcohol metabolism and its expression in human peripheral blood leukocytes. Nihon Arukoru Yakubutsu Igakkai Zasshi 2006, 41:108-119.
14. Yokoyama A, Kato H, Yokoyama T, Igaki H, Tsujinaka T, Muto M, Omori T, Kumagai Y, Yokoyama M, Watanabe H. Esophageal squamous cell carcinoma and aldehyde dehydrogenase-2 genotypes in Japanese females. Alcohol Clin Exp Res 2006, 30:491-500. 10.1111/j.1530-0277.2006.00053.x, 16499490.
15. Zhang J, Zotz RB, Li Y, Wang R, Kiel S, Schulz WA, Wen D, Chen Z, Zhang L, Wang S, Gabbert HE, Sarbia M. Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. J Cancer Res Clin Oncol 2004, 130:574-580.
16. Song C, Xing D, Tan W, Wei Q and LD. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001, 61:3272-3275.
17. Yang CX, Matsuo K, Ito H, Shinoda M, Hatooka S, Hirose K, Wakai K, Saito T, Suzuki T, Maeda T, Tajima K. Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis 2005, 26:1285-1290.
18. Liu R, Yin LH, Pu YP. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huaian population, China. Chinese Medical Journal 2007, 120:1797-1802.
19. Xing D, Tan W, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep 2003, 10:1615-1623.
20. Cascorbi I, Henning S, Brockmöller J, Gephart J, Meisel C, Müller JM, Loddenkemper R, Roots I. Substantially reduced risk of cancer of the aero digestive tract in subjects with variant-463A of the myeloperoxidase gene. Cancer Res 2000, 60:644-649.
21. Matsuo K, Hamajima N, Shinoda M, Hatooka S, Inoue M, Takezaki T, Onda H, Tajima K. Possible risk reduction in esophageal cancer associated with MPO -463a allele. Journal of Epidemiology 2001, 11:109-114.
22. Xing DY, Tan W, Song N, Lin DX. Ser 326 Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 2001, 95:140-143. 10.1002/1097-0215(20010520)95:3<140::AID-IJC1024>3.0.CO;2-2, 11307145.
23. Yoshida A, Huang Y, Ikawa M. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc Natl Acad Sci USA 1984, 81:258-261. 10.1073/pnas.81.1.258, 344651, 6582480.
24. Zintzaras E. The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 2010, 9(1). Article21.
25. Zhao D, Wang J, Zhou Y, Li HQ. Cancer incidence during 2000-2004 year of Feicheng rural area in Shandong, China. J cancer Prev Treat 2005, 12:891-894.
26. Harada S, Misawa S, Agarwal DP, Goedde HW. Liver alcohol dehydrogenase and aldehyde dehydrogenase in the Japanese: Isozyme variation and its possible role in alcohol intoxication. Am J Hum Genet 1980, 32:8-15. 1685945, 6987864.
27. Yokoyama A, Muramatsu T, Ohmori T, Makuuchi H, Higuchi S, Matsushita S, Yoshino K, Maruyama K, Nakano M, Ishii H. Multiple primary esophageal and concurrent upper aerodigestive tract cancer and the aldehyde dehydrogenase-2 genotype of Japanese alcoholics. Cancer 1996, 77:1986-1990. 10.1002/(SICI)1097-0142(19960515)77:10<1986::AID-CNCR4>3.0.CO;2-F, 8640660.
28. Hori H, Kawano T, Endo M, Yuasa Y. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. J Clin Gastroenterol 1997, 25:568-575. 10.1097/00004836-199712000-00003, 9451664.
29. Nomura T, Noda H, Shibahara T, Yokoyama A, Muramatsu T, Ohmori T. Aldehyde dehydrogenase 2 and glutathione S-transferase M1 polymorphism in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol 2000, 36:42-46. 10.1016/S1368-8375(99)00048-2, 10889918.
30. Sun F, Tsuritani I, Honda R, Ma ZY, Yamada Y. Association of genetic polymorphisms of alcohol-metabolizing enzymes with excessive alcohol consumption in Japanese men. Hum Genet 1999, 105:295-300. 10.1007/s004390051104, 10543395.
31. Muto M, Nakane M, Hitomi Y, Yoshida S, Sasaki S, Ohtsu A, Yoshida S, Ebihara S, Esumi H. Association between aldehyde dehydrogenase gene polymorphisms and the phenomenon of field cancerization in patients with head and neck cancer. Carcinogenesis 2002, 23(10 pp):1759-1765.
32. Matsuo K, Hamajima N, Shinoda M, Hatooka S, Inoue M, Takezaki T, Tajima K. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 2001, 22:913-916. 10.1093/carcin/22.6.913, 11375898.
33. Ding JH, Li SP, Cao HX, Wu JZ, Gao CM, Su P, Liu YT, Zhou JN, Chang J, Yao GH. Polymorphisms of alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 and esophageal cancer risk in Southeast Chinese males. World J Gastroenterol 2009, 15:2395-2400. 10.3748/wjg.15.2395, 2684609, 19452585.
34. Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and esophageal cancer risk. Int J Cancer 2007, 121:1643-1658. 10.1002/ijc.23044, 17674367.
35. Bailey LB, Gregory JF. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 1999, 129:919-922.
36. Song C, Xing D, Tan W, Wei Q and LD. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001, 61:3272-3275.
37. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR, Mark SD. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003, 12:1222-226.